Table 3.
Stage 1: Pre–COVID-19 | Stage 2: Acute COVID-19 | Stage 3: Chronic/post–COVID-19 |
---|---|---|
| ||
Risk mitigation | Outpatient | Outpatient |
Malnutrition | Nutrition risk assessment | Nutrition risk assessment |
Cardiometabolicb | Healthy eating and lifestyle | Healthy eating and lifestyle |
Immunity/chronic disease | Micronutrient nutriture and support | Standard nutrition and nutrition support |
Social determinants of health | Inpatient: non-ICU or ICU | Micronutrient nutriture and support |
Lifestyle | Nutrition risk assessment | Nutrition and physical therapy |
Transcultural dietary factors | Standard nutrition | Complication-specific nutritiond |
Nutrition support | Infrastructurec | |
Nutrition, insulin, and glycemic control | Inpatient non-ICU or ICU | |
Micronutrient nutriture and support | Nutrition risk assessment | |
Infrastructurec | Chronic critical illness metabolic support | |
Standard nutrition and nutrition support | ||
Micronutrient nutriture and support | ||
Nutrition and physical therapy | ||
Complication-specific nutritiond | ||
Infrastructurec |
COVID-19, coronavirus disease 2019; ICU, intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2.
This 3-stage model is based on the presumed natural history of COVID-19 and applies to pediatric, adult, and geriatric populations, domestic (US) and global.
Cardiometabolic risk factors associated with increased severity of COVID-19 include: hypertension, obesity, diabetes, and cardiovascular disease.
Infrastructural changes needed to address shortages (eg, enteral pumps) and supply chain, redeployments, training, new programs, and adaptive protocols.
COVID-19 complications include encephalopathy, deconditioning, acute kidney injury and chronic kidney disease, hyperglycemia, hypercoagulable/prothrombotic state, cardiac injury, and pulmonary injury.